No Picture
News Feed

POSITIVE DATA PRESENTED ON PIERIS PHARMACEUTICALS’ INHALED ASTHMA PROGRAM AT ERS AND COMPANY STRENGTHENS MANAGEMENT TEAM

PRECLINICAL DATA ON THE IL-4 RECEPTOR ANTAGONIST PRS-060 PRESENTED AT THE EUROPEAN RESPIRATORY SOCIETY CONFERENCE; MARY FITZGERALD, PH.D., TO LEAD PIERIS RESPIRATORY DRUG DEVELOPMENT PROGRAM […]